GNRH1 and ovarian hyperstimulation syndrome: Later on, the GnRH antagonist protocol was found to be even superior to the agonist protocol due to a substantial reduction in ovarian hyperstimulation syndrome (OHSS) [8], without reducing the live birth rates [9].